ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Mar 2026
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
March 2026
Nuclear Technology
February 2026
Fusion Science and Technology
April 2026
Latest News
NRC approves TerraPower construction permit
Today, the Nuclear Regulatory Commission announced that it has approved TerraPower’s construction permit application for Kemmerer Unit 1, the company’s first deployment of Natrium, its flagship sodium fast reactor.
This approval is a significant milestone on three fronts. For TerraPower, it represents another step forward in demonstrating its technology. For the Department of Energy, it reflects progress (despite delays) for the Advanced Reactor Demonstration Program (ARDP). For the NRC, it is the first approval granted to a commercial reactor in nearly a decade—and the first approval of a commercial non–light water reactor in more than 40 years.
Steven J. Stanley, Kat Lennox, Alex Jenkins
Nuclear Technology | Volume 183 | Number 2 | August 2013 | Pages 260-269
Technical Paper | Radiation Measurements and General Instrumentation | doi.org/10.13182/NT12-141
Articles are hosted by Taylor and Francis Online.
The RadBall is a 140-mm (5.5-in.)-diam deployable, passive, nonelectrical gamma hot-spot imaging device that offers a 360-deg view of the deployment area. The device is particularly useful in instances where the radiation fields inside a nuclear facility are unknown, but a suitable decommissioning strategy is required to be planned. The original version of the technology had a number of drawbacks including a relative insensitivity to radiation (at least 3 Gy required), which led to long deployment times, as well as a narrow target dose range (3 to 8 Gy), which meant that the user required prior knowledge of the radiation fields in which the device was to be deployed. The United Kingdom's National Nuclear Laboratory has developed the technology to overcome both of these issues. The developments associated with the new technology are described here, as are some recent tests undertaken at the Sellafield facility in the United Kingdom. The work has resulted in a significant improvement in sensitivity - 150 times - as well as greatly widened the target dose range to between 20 mGy and 50 Gy. The new version of the technology therefore has a much-improved applicability compared to the original technology.